[NKTR] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
04-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 62.88%
YoY- 54.47%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 20,499 21,594 22,023 23,625 21,585 24,822 25,009 -12.44%
PBT -51,169 -137,081 -56,544 -59,204 -158,968 -90,267 -145,649 -50.30%
Tax -47 -63 3,144 -155 100 126 -4 419.18%
NP -51,122 -137,018 -59,688 -59,049 -159,068 -90,393 -145,645 -50.33%
Tax Rate - - - - - - - -
Total Cost 71,621 158,612 81,711 82,674 180,653 115,215 170,654 -44.03%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -249.39 -634.52 -271.03 -249.94 -736.94 -364.16 -582.37 -43.27%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.27 -0.73 -0.32 -0.31 -0.85 -0.49 -0.79 -51.21%
EPS Diluted -0.27 -0.73 -0.32 -0.31 -0.85 -0.49 -0.79 -51.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.